McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Life Sciences and Healthcare Industry Leaders Invest in Tact.ai to Deliver Next Generation Customer Engagement

by McKesson Ventures | Sep 20, 2021 | Press Releases

Tact.ai, an AI company focused on customer engagement for life sciences, has announced a successful new round of financing totaling $33 million. Investors for this round included McKesson Ventures, Lilly, Novartis (dRx Capital), Microsoft’s M12, and Salesforce...

Recent Posts

  • Midi Health Surpasses $1B Valuation, Igniting a New Era for Women’s Health
  • Oath Surgical Announces AI-Native Surgical Centers Powered by NVIDIA
  • Atropos Health Announces AI-Driven Commercial Analytics Solution for Life Science Companies
  • Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking
  • Reimagine Care and Tampa General Hospital Cancer Institute Launch Virtual Cancer Care Collaboration to Reduce Hospitalizations and Elevate Patient Support
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

IN THE NEWS

ABOUT US

CONTACT US

  • Follow
©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings